<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
	<channel>
		<title>Global Pharmaceutical Technology :: Content Updates</title>
		<description>Global Pharmaceutical Technology published by JMC IT Mahal, is the leading pharma title in Online/Print and digital versions serving the information needs of key executives from the world's leading pharmaceutical companies. The magazine covers important Issues and Trends, News, Press Releases shaping the future of the pharmaceutical industry across the world.</description>
		<link>http://www.pharmatechglobal.net</link>
		<lastBuildDate>Tue, 22 May 2012 00:33:54 +0100</lastBuildDate>
		<generator>FeedCreator 1.7.2</generator>
		<image>
			<url>http://www.pharmatechglobal.net/templates/IT_Mahal/images/logo.png</url>
			<title>Powered by JMC IT MAHAL PVT.LTD.</title>
			<link>http://www.pharmatechglobal.net</link>
			<description>Global Pharmaceutical Technology published by JMC IT Mahal, is the leading pharma title in Online/Print and digital versions serving the information needs of key executives from the world's leading pharmaceutical companies. The magazine covers important Issues and Trends, News, Press Releases shaping the future of the pharmaceutical industry across the world.</description>
		</image>
		<item>
			<title>Nuevolution Announces Receipt of Milestone Payment from Boehringer Ingelheim</title>
			<link>http://www.pharmatechglobal.net/knowledge-share/press-releases/nuevolution-announces-receipt-of-milestone-payment-from-boehringer-ingelheim.php</link>
			<description>The payment was triggered following identification of potent small  molecule compounds that have been shown to disrupt the protein-protein...</description>
			<pubDate>Wed, 09 May 2012 10:44:21 +0100</pubDate>
		</item>
		<item>
			<title>Experts for joint ventures in pharma industry</title>
			<link>http://www.pharmatechglobal.net/knowledge-share/news/experts-for-joint-ventures-in-pharma-industry.php</link>
			<description>A number of prominent medical professionals and corporate heads,  belonging to pharma industry of India and Pakistan, have called...</description>
			<pubDate>Mon, 07 May 2012 22:22:00 +0100</pubDate>
		</item>
		<item>
			<title>Vertex Pharmaceuticals Soars on Cystic Fibrosis Drug Study.</title>
			<link>http://www.pharmatechglobal.net/knowledge-share/news/vertex-pharmaceuticals-soars-on-cystic-fibrosis-drug-study.php</link>
			<description>Vertex Pharmaceuticals (VRTX) stock surged almost 50% Monday after the  company said a combination of two drugs helped cystic...</description>
			<pubDate>Sun, 06 May 2012 22:28:09 +0100</pubDate>
		</item>
		<item>
			<title>Idera Pharmaceuticals Announces Efficacy Data for IMO-8400 in Preclinical Models of Lupus and Psoria</title>
			<link>http://www.pharmatechglobal.net/knowledge-share/news/idera-pharmaceuticals-announces-efficacy-data-for-imo-8400-in-preclinical-models-of-lupus-and-psoria.php</link>
			<description>Idera Pharmaceuticals, Inc. IDRA -6.55% today announced data from  preclinical studies of IMO-8400, demonstrating a novel mechanism of...</description>
			<pubDate>Sun, 06 May 2012 20:31:21 +0100</pubDate>
		</item>
		<item>
			<title>Sartorius Stedim Biotech and c-LEcta Sign Sales Agreement</title>
			<link>http://www.pharmatechglobal.net/knowledge-share/press-releases/sartorius-stedim-biotech-and-c-lecta-sign-sales-agreement.php</link>
			<description>Sartorius Stedim Biotech, a leading international pharma and biotech  supplier, and the biotechnology specialist c-LEcta, announce the signing...</description>
			<pubDate>Wed, 02 May 2012 22:17:30 +0100</pubDate>
		</item>
		<item>
			<title>NIH, pharmaceutical giants partner in program to try turning old drugs into new treatments</title>
			<link>http://www.pharmatechglobal.net/knowledge-share/news/nih-pharmaceutical-giants-partner-in-program-to-try-turning-old-drugs-into-new-treatments.php</link>
			<description>Three pharmaceutical giants are unlocking their freezers to see if  government-funded scientists can reinvent some of their old drugs.</description>
			<pubDate>Wed, 02 May 2012 22:01:29 +0100</pubDate>
		</item>
		<item>
			<title>Mimopath-based influenza vaccine protects against both homologous and heterologous challenge</title>
			<link>http://www.pharmatechglobal.net/knowledge-share/press-releases/mimopath-based-influenza-vaccine-protects-against-both-homologous-and-heterologous-challenge.php</link>
			<description>Dutch biotechnology company Mucosis B.V. today announced the publication  in the peer-reviewed journal Vaccine of preclinical data showing that...</description>
			<pubDate>Wed, 02 May 2012 20:20:40 +0100</pubDate>
		</item>
	</channel>
</rss>

